MeTA in the Philippines

1. MeTA in the Philippines Catherine Dauphin Technical officer WHO Country Office for the Philippines

2. Inception April 2007: DFID-WHO scoping work Working group of international partners (WHO, EU, WB, GTZ) and the Department of Health to set-up the MeTA council Philippines December 2007: MeTA Philippines official launch with the first national MeTA forum October 2010: end of MeTA pilot phase

3. MeTA framework in the Philippines Quarterly meeting of a Council of 24 members body with multistakeholder representation: Government Academe Professional groups (pharmacists, doctors, pharmaceutical industry associations) Civil society International partners Monthly meetings of the Executive Committee: Chairman, vice-chairman, secretary, treasurer, heads of technical committees (advocacy and partnership, finance, membership, research) A secretariat: secretary + admin assistant + webmaster

4. MeTA goals in the Philippines Purpose To make information available and to establish systems and mechanisms for transparency along medicines registration, selection, procurement and use Specific Objectives Making available information on quality and registration of medicines, availability, pricing, ethical promotion and national and local policies on access to essential medicines Setting up of structures and systems for disclosure of information at the national and local government levels Improving technical capacity for disclosing, analyzing and using information and evidence in decision-making Setting up mechanisms for advocacy and participation in decision-making processes (“getting the message out”) Sustaining multi-stakeholder collaboration

5. Making information available Building a common understanding Using standardized tools… Pharmaceutical context - Pharmaceutical Sector Scan Regulatory context - Disclosure survey Access to medicines assessment - WHO facility and household surveys and ad hoc surveys Medicines financing mechanism for the poor Promotional practices

6. Improving systems and capacity for information disclosure and evidence use in decision making Regional Consultation on the Electronic Essential Drug Price Monitoring System (eEDPMS)  Multi-Stakeholder Workshops on Ethical Drug Promotions and Marketing

7. Contribution to the WHO Good Governance on Medicines Awards Pharmaceutical Management and Good Governance Course for LGU Health Managers and Local Chief Executives Workshop for finalizing Core Indicators and Survey Tools for a Pharmacy Benchbook Improving systems and capacity for information disclosure and evidence use in decision making

8. Set up mechanisms for advocacy and participation in decision-making processes MeTA Roundtable Discussions / MeTA Discussion Series: Publications of researches, studies and proceedings MeTA Philippines Website 3 annual MeTA forums 2 national summits on Transparency and Governance in Universal Health Care TV Documentary on Universal Health Care Trips+ position paper and advocacy meeting

9. Conclusions and next steps Major achievement: built and sustain a multistakeholder dialogue establish a common understanding of access to medicines Get the message out MeTA ability to influence policy is difficult to measure: 2 years pilot mainly dedicated to build trust and background analysis How do we measure influence? Where do we set the expectations? MeTA 2: 1 week visit of the International Secretariat to work on MeTA2 framework in the Philipines (Nov 21st – Nov 25th) Consultation and elaboration of MeTA 2 workplan by January 2012

10. Thank you Catherine Dauphin Email:dauphinc@wpro.who.int MeTA Philippines website: www.metaphilippines.org.ph